ICD125J ;ALB/DMR - YEARLY DRG UPDATE; October 01, 2025@15:42
;;18.0;DRG Grouper;**125**;October 20, 2000;Build 4
;Per VA Directive 6402, this routine should not be modified.
; Updates for DRGS 640-809
Q
;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
;;640^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC^1.3356^3.6
;;641^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC^0.7782^2.6
;;642^10^MED^INBORN AND OTHER DISORDERS OF METABOLISM^1.4221^3.4
;;643^10^MED^ENDOCRINE DISORDERS WITH MCC^1.6461^4.9
;;644^10^MED^ENDOCRINE DISORDERS WITH CC^1.025^3.4
;;645^10^MED^ENDOCRINE DISORDERS WITHOUT CC/MCC^0.7683^2.7
;;650^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITH MCC^4.7014^6.3
;;651^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITHOUT MCC^3.7058^5.5
;;652^11^SURG^KIDNEY TRANSPLANT^3.2295^4.3
;;653^11^SURG^MAJOR BLADDER PROCEDURES WITH MCC^5.1964^9.5
;;654^11^SURG^MAJOR BLADDER PROCEDURES WITH CC^2.7993^5.1
;;655^11^SURG^MAJOR BLADDER PROCEDURES WITHOUT CC/MCC^2.1166^3.2
;;656^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC^3.1838^5
;;657^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC^1.83^2.5
;;658^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC^1.5518^1.6
;;659^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MCC^2.5409^5.7
;;660^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC^1.3217^2.8
;;661^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC^1.0354^1.8
;;662^11^SURG^MINOR BLADDER PROCEDURES WITH MCC^3.0615^7.1
;;663^11^SURG^MINOR BLADDER PROCEDURES WITH CC^1.5202^3.6
;;664^11^SURG^MINOR BLADDER PROCEDURES WITHOUT CC/MCC^1.0469^2.1
;;665^11^SURG^PROSTATECTOMY WITH MCC^3.1212^7.1
;;666^11^SURG^PROSTATECTOMY WITH CC^1.7493^3.6
;;667^11^SURG^PROSTATECTOMY WITHOUT CC/MCC^1.1062^2.1
;;668^11^SURG^TRANSURETHRAL PROCEDURES WITH MCC^2.92^7.2
;;669^11^SURG^TRANSURETHRAL PROCEDURES WITH CC^1.552^3.7
;;670^11^SURG^TRANSURETHRAL PROCEDURES WITHOUT CC/MCC^0.9773^2
;;671^11^SURG^URETHRAL PROCEDURES WITH CC/MCC^1.795^3.9
;;672^11^SURG^URETHRAL PROCEDURES WITHOUT CC/MCC^1.0795^1.6
;;673^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC^4.2016^10.2
;;674^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH CC^2.3386^5.5
;;675^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITHOUT CC/MCC^1.6414^2.8
;;682^11^MED^RENAL FAILURE WITH MCC^1.481^4.3
;;683^11^MED^RENAL FAILURE WITH CC^0.8758^3
;;684^11^MED^RENAL FAILURE WITHOUT CC/MCC^0.6003^2.2
;;686^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC^1.8037^5.1
;;687^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH CC^1.0478^3.3
;;688^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC^0.7903^2
;;689^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITH MCC^1.1603^3.8
;;690^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC^0.8095^2.8
;;693^11^MED^URINARY STONES WITH MCC^1.3445^3.7
;;694^11^MED^URINARY STONES WITHOUT MCC^0.7817^2.1
;;695^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITH MCC^1.1438^3.6
;;696^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITHOUT MCC^0.689^2.3
;;697^11^MED^URETHRAL STRICTURE^1.0778^2.6
;;698^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC^1.6544^4.8
;;699^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH CC^1.015^3.2
;;700^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITHOUT CC/MCC^0.6899^2.3
;;707^12^SURG^MAJOR MALE PELVIC PROCEDURES WITH CC/MCC^2.0003^2.2
;;708^12^SURG^MAJOR MALE PELVIC PROCEDURES WITHOUT CC/MCC^1.5342^1.4
;;709^12^SURG^PENIS PROCEDURES WITH CC/MCC^2.3271^4
;;710^12^SURG^PENIS PROCEDURES WITHOUT CC/MCC^1.4012^1.6
;;711^12^SURG^TESTES PROCEDURES WITH CC/MCC^2.0838^4.8
;;712^12^SURG^TESTES PROCEDURES WITHOUT CC/MCC^1.0997^2.3
;;713^12^SURG^TRANSURETHRAL PROSTATECTOMY WITH CC/MCC^1.5034^2.4
;;714^12^SURG^TRANSURETHRAL PROSTATECTOMY WITHOUT CC/MCC^1.0574^1.5
;;715^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITH CC/MCC^2.2373^5
;;716^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITHOUT CC/MCC^1.471^1.6
;;717^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITH CC/MCC^1.8905^3.6
;;718^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITHOUT CC/MCC^1.3431^1.9
;;722^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC^1.8097^5
;;723^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC^1.1427^3.4
;;724^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6117^1.8
;;725^12^MED^BENIGN PROSTATIC HYPERTROPHY WITH MCC^1.1702^3.8
;;726^12^MED^BENIGN PROSTATIC HYPERTROPHY WITHOUT MCC^0.722^2.5
;;727^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITH MCC^1.4829^4.5
;;728^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITHOUT MCC^0.8112^2.9
;;729^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITH CC/MCC^1.0587^3.1
;;730^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITHOUT CC/MCC^0.672^1.8
;;734^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH CC/MCC^2.13^3.1
;;735^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT CC/MCC^1.3455^1.7
;;736^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC^3.5745^6.1
;;737^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC^2.0606^3.7
;;738^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.4685^2.3
;;739^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC^3.5263^5.1
;;740^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC^1.8096^2.6
;;741^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.4261^1.5
;;742^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC^1.8348^2.7
;;743^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC^1.2407^1.5
;;744^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITH CC/MCC^2.0491^4.6
;;745^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITHOUT CC/MCC^1.1375^2
;;746^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITH CC/MCC^1.7371^3.1
;;747^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT CC/MCC^0.8395^1.3
;;748^13^SURG^FEMALE REPRODUCTIVE SYSTEM RECONSTRUCTIVE PROCEDURES^1.3873^1.4
;;749^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH CC/MCC^2.5676^5.1
;;750^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITHOUT CC/MCC^1.4758^1.9
;;754^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.8417^5.1
;;755^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC^1.0878^3.2
;;756^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.9605^2
;;757^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.4319^4.6
;;758^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH CC^0.979^3.6
;;759^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6636^2.4
;;760^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITH CC/MCC^1.0075^2.8
;;761^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITHOUT CC/MCC^0.5696^1.7
;;768^14^SURG^VAGINAL DELIVERY WITH O.R. PROCEDURES EXCEPT STERILIZATION AND/OR D&C^1.0716^2.7
;;769^14^SURG^POSTPARTUM AND POST ABORTION DIAGNOSES WITH O.R. PROCEDURES^1.6898^3
;;770^14^SURG^ABORTION WITH D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY^1.0027^1.9
;;776^14^MED^POSTPARTUM AND POST ABORTION DIAGNOSES WITHOUT O.R. PROCEDURES^0.6547^2.4
;;779^14^MED^ABORTION WITHOUT D&C^0.7131^1.5
;;783^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH MCC^2.4551^4.9
;;784^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH CC^1.0601^3.1
;;785^14^SURG^CESAREAN SECTION WITH STERILIZATION WITHOUT CC/MCC^0.9578^2.6
;;786^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH MCC^1.6495^4.4
;;787^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH CC^1.1168^3.4
;;788^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITHOUT CC/MCC^0.9588^2.9
;;789^15^MED^NEONATES, DIED OR TRANSFERRED TO ANOTHER ACUTE CARE FACILITY^1.8022^1.8
;;790^15^MED^EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME, NEONATE^5.9435^17.9
;;791^15^MED^PREMATURITY WITH MAJOR PROBLEMS^4.059^13.3
;;792^15^MED^PREMATURITY WITHOUT MAJOR PROBLEMS^2.4492^8.6
;;793^15^MED^FULL TERM NEONATE WITH MAJOR PROBLEMS^4.1696^4.7
;;794^15^MED^NEONATE WITH OTHER SIGNIFICANT PROBLEMS^1.4759^3.4
;;795^15^MED^NORMAL NEWBORN^0.1998^3.1
;;796^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH MCC^1.167^3.5
;;797^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH CC^1.0004^2.5
;;798^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITHOUT CC/MCC^0.9571^2.3
;;799^16^SURG^SPLENIC PROCEDURES WITH MCC^4.5289^6.8
;;800^16^SURG^SPLENIC PROCEDURES WITH CC^2.8094^3.9
;;801^16^SURG^SPLENIC PROCEDURES WITHOUT CC/MCC^1.9089^2.4
;;802^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MCC^3.9841^7.8
;;803^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH CC^1.8589^3.7
;;804^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITHOUT CC/MCC^1.356^1.7
;;805^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH MCC^1.0792^3
;;806^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH CC^0.754^2.4
;;807^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITHOUT CC/MCC^0.6742^2
;;808^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC^2.2079^5.2
;;809^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC^1.2659^3.3
;;EXIT
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HICD125J 9944 printed Jan 29, 2026@14:46:05 Page 2
ICD125J ;ALB/DMR - YEARLY DRG UPDATE; October 01, 2025@15:42
+1 ;;18.0;DRG Grouper;**125**;October 20, 2000;Build 4
+2 ;Per VA Directive 6402, this routine should not be modified.
+3 ; Updates for DRGS 640-809
+4 QUIT
+5 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
+1 ;;640^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC^1.3356^3.6
+2 ;;641^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC^0.7782^2.6
+3 ;;642^10^MED^INBORN AND OTHER DISORDERS OF METABOLISM^1.4221^3.4
+4 ;;643^10^MED^ENDOCRINE DISORDERS WITH MCC^1.6461^4.9
+5 ;;644^10^MED^ENDOCRINE DISORDERS WITH CC^1.025^3.4
+6 ;;645^10^MED^ENDOCRINE DISORDERS WITHOUT CC/MCC^0.7683^2.7
+7 ;;650^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITH MCC^4.7014^6.3
+8 ;;651^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITHOUT MCC^3.7058^5.5
+9 ;;652^11^SURG^KIDNEY TRANSPLANT^3.2295^4.3
+10 ;;653^11^SURG^MAJOR BLADDER PROCEDURES WITH MCC^5.1964^9.5
+11 ;;654^11^SURG^MAJOR BLADDER PROCEDURES WITH CC^2.7993^5.1
+12 ;;655^11^SURG^MAJOR BLADDER PROCEDURES WITHOUT CC/MCC^2.1166^3.2
+13 ;;656^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC^3.1838^5
+14 ;;657^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC^1.83^2.5
+15 ;;658^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC^1.5518^1.6
+16 ;;659^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MCC^2.5409^5.7
+17 ;;660^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC^1.3217^2.8
+18 ;;661^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC^1.0354^1.8
+19 ;;662^11^SURG^MINOR BLADDER PROCEDURES WITH MCC^3.0615^7.1
+20 ;;663^11^SURG^MINOR BLADDER PROCEDURES WITH CC^1.5202^3.6
+21 ;;664^11^SURG^MINOR BLADDER PROCEDURES WITHOUT CC/MCC^1.0469^2.1
+22 ;;665^11^SURG^PROSTATECTOMY WITH MCC^3.1212^7.1
+23 ;;666^11^SURG^PROSTATECTOMY WITH CC^1.7493^3.6
+24 ;;667^11^SURG^PROSTATECTOMY WITHOUT CC/MCC^1.1062^2.1
+25 ;;668^11^SURG^TRANSURETHRAL PROCEDURES WITH MCC^2.92^7.2
+26 ;;669^11^SURG^TRANSURETHRAL PROCEDURES WITH CC^1.552^3.7
+27 ;;670^11^SURG^TRANSURETHRAL PROCEDURES WITHOUT CC/MCC^0.9773^2
+28 ;;671^11^SURG^URETHRAL PROCEDURES WITH CC/MCC^1.795^3.9
+29 ;;672^11^SURG^URETHRAL PROCEDURES WITHOUT CC/MCC^1.0795^1.6
+30 ;;673^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC^4.2016^10.2
+31 ;;674^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH CC^2.3386^5.5
+32 ;;675^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITHOUT CC/MCC^1.6414^2.8
+33 ;;682^11^MED^RENAL FAILURE WITH MCC^1.481^4.3
+34 ;;683^11^MED^RENAL FAILURE WITH CC^0.8758^3
+35 ;;684^11^MED^RENAL FAILURE WITHOUT CC/MCC^0.6003^2.2
+36 ;;686^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC^1.8037^5.1
+37 ;;687^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH CC^1.0478^3.3
+38 ;;688^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC^0.7903^2
+39 ;;689^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITH MCC^1.1603^3.8
+40 ;;690^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC^0.8095^2.8
+41 ;;693^11^MED^URINARY STONES WITH MCC^1.3445^3.7
+42 ;;694^11^MED^URINARY STONES WITHOUT MCC^0.7817^2.1
+43 ;;695^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITH MCC^1.1438^3.6
+44 ;;696^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITHOUT MCC^0.689^2.3
+45 ;;697^11^MED^URETHRAL STRICTURE^1.0778^2.6
+46 ;;698^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC^1.6544^4.8
+47 ;;699^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH CC^1.015^3.2
+48 ;;700^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITHOUT CC/MCC^0.6899^2.3
+49 ;;707^12^SURG^MAJOR MALE PELVIC PROCEDURES WITH CC/MCC^2.0003^2.2
+50 ;;708^12^SURG^MAJOR MALE PELVIC PROCEDURES WITHOUT CC/MCC^1.5342^1.4
+51 ;;709^12^SURG^PENIS PROCEDURES WITH CC/MCC^2.3271^4
+52 ;;710^12^SURG^PENIS PROCEDURES WITHOUT CC/MCC^1.4012^1.6
+53 ;;711^12^SURG^TESTES PROCEDURES WITH CC/MCC^2.0838^4.8
+54 ;;712^12^SURG^TESTES PROCEDURES WITHOUT CC/MCC^1.0997^2.3
+55 ;;713^12^SURG^TRANSURETHRAL PROSTATECTOMY WITH CC/MCC^1.5034^2.4
+56 ;;714^12^SURG^TRANSURETHRAL PROSTATECTOMY WITHOUT CC/MCC^1.0574^1.5
+57 ;;715^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITH CC/MCC^2.2373^5
+58 ;;716^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITHOUT CC/MCC^1.471^1.6
+59 ;;717^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITH CC/MCC^1.8905^3.6
+60 ;;718^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITHOUT CC/MCC^1.3431^1.9
+61 ;;722^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC^1.8097^5
+62 ;;723^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC^1.1427^3.4
+63 ;;724^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6117^1.8
+64 ;;725^12^MED^BENIGN PROSTATIC HYPERTROPHY WITH MCC^1.1702^3.8
+65 ;;726^12^MED^BENIGN PROSTATIC HYPERTROPHY WITHOUT MCC^0.722^2.5
+66 ;;727^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITH MCC^1.4829^4.5
+67 ;;728^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITHOUT MCC^0.8112^2.9
+68 ;;729^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITH CC/MCC^1.0587^3.1
+69 ;;730^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITHOUT CC/MCC^0.672^1.8
+70 ;;734^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH CC/MCC^2.13^3.1
+71 ;;735^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT CC/MCC^1.3455^1.7
+72 ;;736^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC^3.5745^6.1
+73 ;;737^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC^2.0606^3.7
+74 ;;738^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.4685^2.3
+75 ;;739^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC^3.5263^5.1
+76 ;;740^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC^1.8096^2.6
+77 ;;741^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.4261^1.5
+78 ;;742^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC^1.8348^2.7
+79 ;;743^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC^1.2407^1.5
+80 ;;744^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITH CC/MCC^2.0491^4.6
+81 ;;745^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITHOUT CC/MCC^1.1375^2
+82 ;;746^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITH CC/MCC^1.7371^3.1
+83 ;;747^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT CC/MCC^0.8395^1.3
+84 ;;748^13^SURG^FEMALE REPRODUCTIVE SYSTEM RECONSTRUCTIVE PROCEDURES^1.3873^1.4
+85 ;;749^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH CC/MCC^2.5676^5.1
+86 ;;750^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITHOUT CC/MCC^1.4758^1.9
+87 ;;754^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.8417^5.1
+88 ;;755^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC^1.0878^3.2
+89 ;;756^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.9605^2
+90 ;;757^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.4319^4.6
+91 ;;758^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH CC^0.979^3.6
+92 ;;759^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6636^2.4
+93 ;;760^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITH CC/MCC^1.0075^2.8
+94 ;;761^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITHOUT CC/MCC^0.5696^1.7
+95 ;;768^14^SURG^VAGINAL DELIVERY WITH O.R. PROCEDURES EXCEPT STERILIZATION AND/OR D&C^1.0716^2.7
+96 ;;769^14^SURG^POSTPARTUM AND POST ABORTION DIAGNOSES WITH O.R. PROCEDURES^1.6898^3
+97 ;;770^14^SURG^ABORTION WITH D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY^1.0027^1.9
+98 ;;776^14^MED^POSTPARTUM AND POST ABORTION DIAGNOSES WITHOUT O.R. PROCEDURES^0.6547^2.4
+99 ;;779^14^MED^ABORTION WITHOUT D&C^0.7131^1.5
+100 ;;783^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH MCC^2.4551^4.9
+101 ;;784^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH CC^1.0601^3.1
+102 ;;785^14^SURG^CESAREAN SECTION WITH STERILIZATION WITHOUT CC/MCC^0.9578^2.6
+103 ;;786^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH MCC^1.6495^4.4
+104 ;;787^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH CC^1.1168^3.4
+105 ;;788^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITHOUT CC/MCC^0.9588^2.9
+106 ;;789^15^MED^NEONATES, DIED OR TRANSFERRED TO ANOTHER ACUTE CARE FACILITY^1.8022^1.8
+107 ;;790^15^MED^EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME, NEONATE^5.9435^17.9
+108 ;;791^15^MED^PREMATURITY WITH MAJOR PROBLEMS^4.059^13.3
+109 ;;792^15^MED^PREMATURITY WITHOUT MAJOR PROBLEMS^2.4492^8.6
+110 ;;793^15^MED^FULL TERM NEONATE WITH MAJOR PROBLEMS^4.1696^4.7
+111 ;;794^15^MED^NEONATE WITH OTHER SIGNIFICANT PROBLEMS^1.4759^3.4
+112 ;;795^15^MED^NORMAL NEWBORN^0.1998^3.1
+113 ;;796^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH MCC^1.167^3.5
+114 ;;797^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH CC^1.0004^2.5
+115 ;;798^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITHOUT CC/MCC^0.9571^2.3
+116 ;;799^16^SURG^SPLENIC PROCEDURES WITH MCC^4.5289^6.8
+117 ;;800^16^SURG^SPLENIC PROCEDURES WITH CC^2.8094^3.9
+118 ;;801^16^SURG^SPLENIC PROCEDURES WITHOUT CC/MCC^1.9089^2.4
+119 ;;802^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MCC^3.9841^7.8
+120 ;;803^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH CC^1.8589^3.7
+121 ;;804^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITHOUT CC/MCC^1.356^1.7
+122 ;;805^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH MCC^1.0792^3
+123 ;;806^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH CC^0.754^2.4
+124 ;;807^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITHOUT CC/MCC^0.6742^2
+125 ;;808^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC^2.2079^5.2
+126 ;;809^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC^1.2659^3.3
+127 ;;EXIT
